Skip to main content
SpringerLink
Log in

Prognostic Significance of Pretreatment Laboratory Parameters in Combined Small-Cell Lung Cancer

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Despite the increasing incidence of combined small-cell lung cancer (C-SCLC) in recent years, there have not been many data on clinical prognostic factors predicting prognosis of C-SCLC patients. In present study, we sought pretreatment features especially basic laboratory parameters predicting survival of C-SCLC. We analyzed 613 small-cell lung cancer (SCLC) patients at our institution between January 2005 and December 2010. We identified 114 patients with C-SCLC. The pathologic and clinical characteristics of these patients were reviewed. Data of laboratory parameters obtained during regular examinations at diagnosis of these patients were examined. The Kaplan–Meier method was used to calculate the survival rate and depict the survival curves. The Cox regression model was used to analyze the independent factors affecting the overall survival (OS). These data were compared with the results obtained from our 499 pure SCLC patients who presented during the same time period. Of the 613 SCLC patients analyzed, 18.6 % of the patients presented with C-SCLC. No difference in OS was observed in patients with C-SCLC and patients with pure SCLC (P = 0.995). The Kaplan–Meier survival curves revealed that poor ECOG-PS (P < 0.001), extensive disease (P < 0.001), pathologic subtype of SC/LC (P < 0.001), not receiving surgery (P = 0.001), elevated serum lactate dehydrogenase (LDH) (P = 0.005), elevated NSE (P = 0.043), and elevated neutrophile–lymphocyte ratio (NLR) (P = 0.018) were associated with adverse prognosis of patients with C-SCLC. By multivariate analysis, OS was affected by ECOG-PS (hazard ratio 2.001, P = 0.012), disease extent (hazard ratio 3.406, P < 0.001), and NLR (hazard ratio 1.704, P = 0.030) in C-SCLC patients, while the risk factors that influenced the prognosis of the patients with pure SCLC were ECOG-PS (hazard ratio 2.132, P < 0.001), disease extent (hazard ratio 1.482, P < 0.001), and LDH (hazard ratio 1.811, P < 0.001). Patients with C-SCLC carry a similar prognosis than those with pure small-cell variety. Easily accessible pretreatment parameters such as NLR should be considered in defining the prognosis of C-SCLC patients besides disease extent and performance status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Govindan, R., et al. (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology, 24(28), 4539–4544.

    Article  PubMed  Google Scholar 

  2. Osterlind, K., & Andersen, P. K. (1986). Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Research, 46(8), 4189–4194.

    CAS  PubMed  Google Scholar 

  3. Maestu, I., et al. (1997). Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology, 8(6), 547–553.

    Article  CAS  PubMed  Google Scholar 

  4. Kawahara, M., et al. (1997). Prognostic factors and prognostic staging system for small cell lung cancer. Japanese Journal of Clinical Oncology, 27(3), 158–165.

    Article  CAS  PubMed  Google Scholar 

  5. Cerny, T., et al. (1987). Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. International Journal of Cancer, 39(2), 146–149.

    Article  CAS  Google Scholar 

  6. Souhami, R. L., et al. (1985). Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Research, 45(6), 2878–2882.

    CAS  PubMed  Google Scholar 

  7. Rawson, N. S., & Peto, J. (1990). An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of lung cancer of the United Kingdom coordinating committee on cancer research. British Journal of Cancer, 61(4), 597–604.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Dearing, M. P., et al. (1990). Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. Journal of Clinical Oncology, 8(6), 1042–1049.

    CAS  PubMed  Google Scholar 

  9. Paesmans, M., et al. (2000). Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer, 89(3), 523–533.

    Article  CAS  PubMed  Google Scholar 

  10. Teramukai, S., et al. (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan multinational trial organisation LC00-03. European Journal of Cancer, 45(11), 1950–1958.

    Article  PubMed  Google Scholar 

  11. Sarraf, K. M., et al. (2009). Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery, 137(2), 425–428.

    Article  PubMed  Google Scholar 

  12. Lee, S., et al. (2013). Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer, 13, 350.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. McMillan, D. C. (2009). Systemic inflammation, nutritional status and survival in patients with cancer. Current Opinion in Clinical Nutrition and Metabolic Care, 12(3), 223–226.

    Article  PubMed  Google Scholar 

  14. He, W., et al. (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Medical Oncology, 30(1), 439.

    Article  PubMed  Google Scholar 

  15. Azab, B., et al. (2013). Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Medical Oncology, 30(1), 432.

    Article  PubMed  Google Scholar 

  16. Lee, Y., et al. (2009). Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Journal of Cancer Research and Clinical Oncology, 138(12), 2009–2016.

    Article  Google Scholar 

  17. Travis, W. D., et al. (2004). Tumours of the lung, pleura, thymus and heart: world health organization: international histological classification of tumours. Lyon: IARC Press.

    Google Scholar 

  18. Adelstein, D. J., et al. (1986). Mixed small cell and non-small cell lung cancer. Chest, 89(5), 699–704.

    Article  CAS  PubMed  Google Scholar 

  19. Mangum, M. D., et al. (1989). Combined small-cell and non-small-cell lung cancer. Journal of Clinical Oncology, 7(5), 607–612.

    CAS  PubMed  Google Scholar 

  20. Nicholson, S. A., et al. (2002). Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. American Journal of Surgical Pathology, 26(9), 1184–1197.

    Article  PubMed  Google Scholar 

  21. Hage, R., et al. (1998). Surgery for combined type small cell lung carcinoma. Thorax, 53(6), 450–453.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Babakoohi, S., et al. (2012). Combined SCLC clinical and pathologic characteristics. Clinical Lung Cancer, 14(2), 113–119.

    Article  PubMed  Google Scholar 

  23. Kim, Y. H., Mishima, M., & Date, H. (2013). “Combined” small cell and “pure” small cell lung cancer: is there a clinical difference? Medical Oncology, 30(2), 600.

    Article  CAS  PubMed  Google Scholar 

  24. Tatematsu, A., et al. (2008). Epidermal growth factor receptor mutations in small cell lung cancer. Clinical Cancer Research, 14(19), 6092–6096.

    Article  CAS  PubMed  Google Scholar 

  25. Cedres, S., et al. (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clinical and Translational Oncology, 14(11), 864–869.

    Article  CAS  PubMed  Google Scholar 

  26. Tomita, M., et al. (2011). Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Research, 31(9), 2995–2998.

    PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (Nos. 81372517 and 81000899), the Tianjin Municipal Science and Technology Commission Key Application Research Projects (No. 11JCZDJC18900), and the Science Foundation of Tianjin Health Bureau (No. 2010KZ78)

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    Xinyue Wang, Richeng Jiang & Kai Li

  2. Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

    Xinyue Wang, Richeng Jiang & Kai Li

  3. Department of Thoracic Oncology, Cancer Institute and Hospital of Tianjin Medical University, Huanhuxi Road, Hexi District, Tianjin, 300060, China

    Xinyue Wang, Richeng Jiang & Kai Li

Authors
  1. Xinyue Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kai Li.

Additional information

Xinyue Wang and Richeng Jiang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, X., Jiang, R. & Li, K. Prognostic Significance of Pretreatment Laboratory Parameters in Combined Small-Cell Lung Cancer. Cell Biochem Biophys 69, 633–640 (2014). https://doi.org/10.1007/s12013-014-9845-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9845-3

Keywords

Search

Navigation